Globally more that than 16.6 million people have been infected with SARS-CoV-2. One of the vexing uncertainties of the infection is its unpredictable nature. Healthcare professionals find it challenging to make informed decisions on treatment strategies. A recent study done by Irish researchers published in the British Medical Journal in July 2020 reports a bidirectional relationship between COVID-19 and abnormalities in coagulation. Read on to know about this new clinical feature of COVID-19.
Hypercoagulability in COVID-19 Patients with severe COVID-19 have demonstrated an unexpected propensity to develop deep vein thromboembolism. These patients also have a high D-dimer level. Additionally, It was noted that there was a higher risk of thrombosis in patients with a history of hypertension, diabetes, and other cardiovascular risk factors. Moreover, autopsy studies of COVID-19 patients…
